301 related articles for article (PubMed ID: 15584047)
61. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing?
Liman AK; Giampoli EJ; Bonfiglio TA
Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044
[TBL] [Abstract][Full Text] [Related]
62. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
63. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
[TBL] [Abstract][Full Text] [Related]
64. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
65. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
66. p16(INK4a) is a useful marker of human papillomavirus integration allowing risk stratification for cervical malignancies.
Cheah PL; Looi LM; Teoh KH; Mun KS; Nazarina AR
Asian Pac J Cancer Prev; 2012; 13(2):469-72. PubMed ID: 22524808
[TBL] [Abstract][Full Text] [Related]
67. Are adjunctive markers useful in routine cervical cancer screening? Application of p16(INK4a) and HPV-PCR on ThinPrep samples with histological follow-up.
Schledermann D; Andersen BT; Bisgaard K; Dohse M; Ejersbo D; Hoelund B; Horal P; Lindh M; Ryd W
Diagn Cytopathol; 2008 Jul; 36(7):453-9. PubMed ID: 18528890
[TBL] [Abstract][Full Text] [Related]
68. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
[TBL] [Abstract][Full Text] [Related]
69. Diagnostic performance of p16 staining in atypical squamous cells 'cannot exclude high-grade squamous epithelial lesion' in predicting high-grade cervical pathology.
Pabuccu EG; Taskin S; Ustun H; Gungor M; Aytac R; Yalcin I; Ortac F
J Obstet Gynaecol; 2014 Nov; 34(8):730-4. PubMed ID: 24999727
[TBL] [Abstract][Full Text] [Related]
70. Combined detection of p16(INK4a) and IMP3 increase the concordance rate between cervical cytologic and histologic diagnosis.
Wei Q; Fu B; Liu J; Xu J; Zhao T
Int J Clin Exp Pathol; 2013; 6(8):1549-57. PubMed ID: 23923073
[TBL] [Abstract][Full Text] [Related]
71. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus.
Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS
Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296
[TBL] [Abstract][Full Text] [Related]
72. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
[TBL] [Abstract][Full Text] [Related]
73. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
Yu J; Zhu HT; Zhao JJ; Su JZ; Xia YD
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):323-326. PubMed ID: 28468038
[No Abstract] [Full Text] [Related]
74. p16 INK4A is a strong biomarker for cervical intraepithelial neoplasia and invasive cervical carcinoma: a reappraisal.
Haidopoulos D; Partsinevelos GA; Vlachos GD; Rodolakis A; Markaki S; Voulgaris Z; Diakomanolis E; Antsaklis A
Reprod Sci; 2009 Jul; 16(7):685-93. PubMed ID: 19372590
[TBL] [Abstract][Full Text] [Related]
75. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
76. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
[TBL] [Abstract][Full Text] [Related]
77. Off-label high-risk HPV DNA testing of vaginal ASC-US and LSIL cytologic abnormalities at Parkland hospital.
Chappell CA; West AM; Kabbani W; Werner CL
J Low Genit Tract Dis; 2010 Oct; 14(4):352-5. PubMed ID: 20885164
[TBL] [Abstract][Full Text] [Related]
78. P16(INK4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Acta Cytol; 2007; 51(5):755-66. PubMed ID: 17910346
[TBL] [Abstract][Full Text] [Related]
79. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests.
Toll AD; Kelly D; Maleki Z
Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
